Last update 23 Jan 2025

HER3 x EGFR x Tubulin

Basic Info

Related Targets
HER3EGFRTubulin

Related

1
Drugs associated with HER3 x EGFR x Tubulin
BCG-019
Target
EGFR x HER3 x Tubulin
Mechanism
EGFR modulators [+2]
Active Org.
Biocytogen Pharmaceuticals (Beijing) Co., Ltd.Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
Originator Org.
Biocytogen Pharmaceuticals (Beijing) Co., Ltd.Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
Active Indication
Colorectal Cancer [+2]
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date20 Jan 1800
100 Clinical Results associated with HER3 x EGFR x Tubulin
Login to view more data
100 Translational Medicine associated with HER3 x EGFR x Tubulin
Login to view more data
0 Patents (Medical) associated with HER3 x EGFR x Tubulin
Login to view more data
1
Literatures (Medical) associated with HER3 x EGFR x Tubulin
06 May 1998Journal of the Society for Gynecologic Investigation
Expression of the ErbB Family of Receptors in Ovarian Cancer

Analysis

Perform a panoramic analysis of this field.
login
or
view full example data
Perform a panoramic analysis of this field.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free